Thomas J Yockachonis (Thomas Yockachonis)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Genetic Diversity

Respiratory Syndrome Coronavirus

Monoclonal Antibody

Pluripotent Stem Cells

Top Venues

Science translational medicine

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I Kaku, Michael E Brown, Elizabeth Champney, James C Geoghegan, Maximiliano Vásquez, Eric M Krauland, Thomas J Yockachonis, Shuangyi Bai, Bronwyn M Gunn, Anthony Cammarata, Christopher M Rubino, Paul Ambrose, Laura M Walker
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science translational medicine 15 (688) (2023)
Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I Kaku, Michael E Brown, Elizabeth Champney, James C Geoghegan, Maximiliano Vásquez, Eric M Krauland, Thomas J Yockachonis, Shuangyi Bai, Bronwyn M Gunn, Anthony Cammarata, Christopher M Rubino, Paul Ambrose, Laura M Walker
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science translational medicine 15 (688) (2023)
C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang, Laura M Deveau, Thomas J Yockachonis, Andrew S Herbert, Michael B Battles, Cecilia M O'Brien, Michael E Brown, James C Geoghegan, Jonathan Belk, Linghang Peng, Linlin Yang, Yixuan J Hou, Trevor D Scobey, Dennis R Burton, David Nemazee, John M Dye, James E Voss, Bronwyn M Gunn, Jason S Mclellan, Ralph S Baric, Lisa E Gralinski, Laura M Walker
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science (New York, N.Y.) 371 (6531) (2021)